A growing number of drug launches have faltered at the final hour because manufacturing processes weren’t up to FDA standards. Some went through that disappointment more than once. How can drug developers properly monitor quality throughout the clinical production process and fix any issues that arise—before the FDA brings out the red flags? In this webinar, we’ll look at the diverse set of tactics companies can use to forestall manufacturing disappointments, from recruitment to partnerships to regulatory communication and more.